Moderne immuntherapie der multiplen sklerose

T. Ziemssen; A. Chan

doi:10.1055/s-2007-986404

Moderne immuntherapie der multiplen sklerose

Translated title of the contribution: State of the art therapy for multiple sclerosis

T. Ziemssen
, A. Chan

Research output: Contribution to journal › Review article › peer-review

Abstract

Considerable progress in different fields of neuroimmunological research has led to a major increase in the therapeutic options available for the treatment of multiple sclerosis over the last decade. This progress not only includes advances in our understanding of the pathophysiology of MS, and biotechnological developments but also improvements in clinical trial design. Here, we will review pathophysiological aspects, clinical rationale and practical issues of current MS therapy.

Translated title of the contribution	State of the art therapy for multiple sclerosis
Original language	German
Pages (from-to)	160-168
Number of pages	9
Journal	Aktuelle Neurologie
Volume	35
Issue number	4
DOIs	https://doi.org/10.1055/s-2007-986404
State	Published - May 2008
Externally published	Yes

Keywords

Escalation therapy
Immunomodulatory therapy
Multiple sclerosis
Relapse therapy

Access to Document

10.1055/s-2007-986404

Cite this

@article{2ec074772d664eec91eb37807daebdd0,

title = "Moderne immuntherapie der multiplen sklerose",

abstract = "Considerable progress in different fields of neuroimmunological research has led to a major increase in the therapeutic options available for the treatment of multiple sclerosis over the last decade. This progress not only includes advances in our understanding of the pathophysiology of MS, and biotechnological developments but also improvements in clinical trial design. Here, we will review pathophysiological aspects, clinical rationale and practical issues of current MS therapy.",

keywords = "Escalation therapy, Immunomodulatory therapy, Multiple sclerosis, Relapse therapy",

author = "T. Ziemssen and A. Chan",

year = "2008",

month = may,

doi = "10.1055/s-2007-986404",

language = "German",

volume = "35",

pages = "160--168",

journal = "Aktuelle Neurologie",

issn = "0302-4350",

publisher = "Georg Thieme Verlag",

number = "4",

}

TY - JOUR

T1 - Moderne immuntherapie der multiplen sklerose

AU - Ziemssen, T.

AU - Chan, A.

PY - 2008/5

Y1 - 2008/5

N2 - Considerable progress in different fields of neuroimmunological research has led to a major increase in the therapeutic options available for the treatment of multiple sclerosis over the last decade. This progress not only includes advances in our understanding of the pathophysiology of MS, and biotechnological developments but also improvements in clinical trial design. Here, we will review pathophysiological aspects, clinical rationale and practical issues of current MS therapy.

AB - Considerable progress in different fields of neuroimmunological research has led to a major increase in the therapeutic options available for the treatment of multiple sclerosis over the last decade. This progress not only includes advances in our understanding of the pathophysiology of MS, and biotechnological developments but also improvements in clinical trial design. Here, we will review pathophysiological aspects, clinical rationale and practical issues of current MS therapy.

KW - Escalation therapy

KW - Immunomodulatory therapy

KW - Multiple sclerosis

KW - Relapse therapy

UR - https://www.scopus.com/pages/publications/44449121909

U2 - 10.1055/s-2007-986404

DO - 10.1055/s-2007-986404

M3 - Review article

AN - SCOPUS:44449121909

SN - 0302-4350

VL - 35

SP - 160

EP - 168

JO - Aktuelle Neurologie

JF - Aktuelle Neurologie

IS - 4

ER -

Moderne immuntherapie der multiplen sklerose

Abstract

Keywords

Access to Document

Fingerprint

Cite this